EOLS Earnings Date: Nov 4, 2026 (Estimated) — Evolus, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is EOLS's next earnings date?
Evolus, Inc. (EOLS) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.05 on revenue of $77.6M.
How did EOLS do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Evolus, Inc. posted EPS of -$0.12 versus the -$0.03 estimate, a miss of 140.0%. Revenue was $84.1M against a $81.5M estimate. The stock's 1-day post-earnings move was +19.9%.
How much does EOLS stock move after earnings?
EOLS beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 16.6% (up or down) in the day after earnings.
About Evolus, Inc.
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.03 | -0.12 | -140.00% | $84.1M | ❌ Miss | +19.90% | +31.39% | +46.44% |
| 2026-05-04 | Q1 2026 | -0.14 | -0.16 | -14.29% | $73.1M | ❌ Miss | +14.16% | +13.26% | +8.06% |
| 2026-03-03 | Q4 2025 | 0.01 | 0.05 | +400.00% | $90.3M | ✅ Beat | +35.35% | +27.84% | +4.36% |
| 2025-11-05 | Q3 2025 | -0.21 | -0.11 | +47.62% | $69.0M | ✅ Beat | +5.43% | +7.20% | +0.59% |
| 2025-08-05 | Q2 2025 | -0.13 | -0.23 | -76.92% | $69.4M | ❌ Miss | -28.51% | -28.17% | -15.71% |
| 2025-03-04 | Q4 2024 | 0.04 | 0.04 | +0.00% | $78.9M | ➖ Inline | -1.25% | -11.43% | -14.84% |
| 2024-11-06 | Q3 2024 | -0.10 | -0.17 | -70.00% | $61.1M | ❌ Miss | -14.99% | -27.13% | -24.69% |
| 2024-07-31 | Q2 2024 | -0.03 | -0.04 | -33.33% | $66.9M | ❌ Miss | +13.04% | +3.95% | +27.46% |
Showing last 8 quarters.